Clinical Trial

A Cryotherapy With Tranexamic Acid Versus Normal Saline in the Treatment of Melasma

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2024 (before its estimated February 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to evaluate the effectiveness of a precision cryotherapy via boosting mode combined with tranexamic acid versus normal saline in the treatment of melasma. Eighteen patients aged 25 to 60 years diagnosed with epidermal-typed melasma sized equal to or more than 2 cm on both cheeks were included. The patients were treated with a precision cryotherapy via boosting mode combined with tranexamic acid and normal saline on each side of cheek for 4 times every 1 week. Then, they were follow up at 1 and 3 months after the last treatment. Subjective assessment of physician and patient improvement were evaluated. Moreover, Melasma Area and Severity Index (MASI), melanin and erythema index using Mexameter were also recorded.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06491771
Lead Sponsor Mahidol University
Conditions Cryotherapy Effect
Enrollment 18 participants
Start Date 2024-07-01
Primary Completion 2025-02-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-09